RxDoctor Payments Data

Courtney Luna

Family · Overland Park, KSNPI 1376243923

Payments from drug & device makers

$3,649in general payments, 2019–2025

Across 177 payments — averaging $20.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$888
  • Sanofi$516
  • GSK$363
  • Regeneron Healthcare Solutions, Inc.$298
  • Takeda Pharmaceuticals U.S.A., Inc.$280
  • Novartis$145
  • plus $1K from 25 others

What the payments were for

  • Consulting fees$180%
  • Food & beverage$3,49896%
  • Education$1334%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,649 in reported general payments places this provider in the 90th percentile of 1,579 family providers in Kansas.

See all family providers in Kansas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$22,036
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$7,314
Breo ElliptaFluticasone/Vilanterol17$6,225
SymbicortBudesonide/Formoterol Fumarate14$6,000
Albuterol Sulfate HfaAlbuterol Sulfate54$1,372
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$1,364
Ipratropium Bromide22$1,030
Azelastine Hcl27$667
Montelukast Sodium67$493
Fluticasone Propionate29$443
Famotidine15$285
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav25$271
Pantoprazole Sodium12$211
Prednisone26$60

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$363$28,26136 claims
AstraZenecaBreztri Aerosphere, Symbicort$888$13,31425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,579 family providers in Kansas.

Other family in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →